— Know what they know.
Not Investment Advice
Also trades as: AKZA.AS (AMS) · $vol 32M · AKZOY (OTC) · $vol 3M

AKZOF OTC

Akzo Nobel N.V.
1W: +3.6% 1M: +3.7% 3M: -1.7% YTD: +2.0% 1Y: -7.8% 3Y: -12.8% 5Y: -32.1%
$66.37
+0.00 (+0.00%)
Pre-Market: $65.44 (-0.93, -1.40%)
Weekly Expected Move ±4.9%
$61 $64 $67 $71 $74
OTC · Basic Materials · Chemicals - Specialty · Tech Score Buy · Power 65 · $11.4B mcap · 154M float · 0.0004% daily turnover · Short 53% of daily vol
Credit Risk of going bust: higher than 62% of companies Debt: 39.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $3.59 (down 95%), Akzo Nobel N.V. would be worth roughly what it owes.
Total debt $7.33B against a stock market value of $11.38B.
Distance to default 4.08 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $4.27B (short-term plus half of long-term), stock volatility 42.7%; Altman Z'' 3.63. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$13.9B -2.1% ▼
5Y CAGR: +1.1%
Total Liabilities
$9.1B -3.2% ▼
5Y CAGR: +4.8%
Shareholders Equity
$4.7B +1.8% ▲
5Y CAGR: -4.1%
Cash & Investments
$1.9B +30.8% ▲
5Y CAGR: +0.7%
Total Debt
$4.9B -9.5% ▼
5Y CAGR: +11.0%
Net Debt
$3.2B -20.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$1.2B$1.4B$1.5B$1.3B$1.6B
Short-Term Investments$58M$336M$265M$165M$302M
Cash & ST Investments$1.2B$1.8B$1.8B$1.5B$1.9B
Net Receivables$2.1B$2.2B$2.2B$2.3B$2.6B
Inventory$1.6B$1.8B$1.6B$1.7B$1.5B
Other Current Assets$478M$434M$391M$150M$0
Total Current Assets$5.3B$6.2B$6.0B$5.8B$6.1B
Property, Plant & Equip.$2.1B$2.3B$2.3B$2.4B$2.3B
Goodwill & Intangibles$3.7B$4.1B$4.1B$4.0B$3.8B
Long-Term Investments$198M-$59M$44M$228M$468M
Other Non-Current Assets$2.1B$1.7B$1.7B$1.7B$1.3B
Total Non-Current Assets$8.5B$8.5B$8.5B$8.4B$7.9B
Total Assets$13.9B$14.7B$14.6B$14.2B$13.9B
— Liabilities —
Accounts Payable$2.4B$2.2B$2.3B$2.7B$2.7B
Short-Term Debt$1.5B$2.5B$2.3B$1.6B$1.1B
Deferred Revenue$348M$0$212M$0$0
Other Current Liabilities$49M$481M$186M$173M$185M
Total Current Liabilities$4.9B$5.7B$5.7B$4.7B$4.2B
Long-Term Debt$1.8B$3.1B$3.0B$3.5B$3.5B
Other Non-Current Liab.$1.4B$1.1B$1.1B$541M$766M
Total Non-Current Liabilities$3.4B$4.4B$4.3B$4.7B$5.3B
Total Liabilities$8.2B$10.2B$10.0B$9.4B$9.1B
— Equity —
Common Stock$91M$87M$85M$85M$86M
Retained Earnings$749M$4.9B$679M$786M$5.4B
Accumulated OCI$0-$690M-$711M$3.7B-$801M
Total Stockholders Equity$5.4B$4.3B$4.3B$4.6B$4.7B
Total Liabilities & Equity$13.9B$14.7B$14.6B$14.2B$13.9B
— Key Metrics —
Total Debt$3.5B$5.9B$5.6B$5.4B$4.9B
Net Debt$2.4B$4.4B$4.0B$4.1B$3.2B
Total Investments$256M$277M$309M$393M$770M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms